• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: Medtronic scales back at former Covidien HQ in Mass.

Report: Medtronic scales back at former Covidien HQ in Mass.

March 9, 2016 By Brad Perriello

MedtronicMedtronic (NYSE:MDT) is scaling back in Mansfield, Mass., as it looks to cut costs  at the former headquarters of its Covidien subsidiary.*

Medtronic spokesman Fernando Vivanco told MassDevice.com today that Medtronic is consolidating from 4 to 3 buildings it leases in Mansfield, about an hour south of Boston.

The move is part of a conversion to a “flexible workspace” that allows employees to work from home or remote locations, Vivanco told us.

“This decision will optimize the physical space we have on campus, while also garnering cost savings. Medtronic started implementing flexible workplaces several years ago and will continue to move to this model globally,” Vivanco said, noting that the move is not related to any layoffs at the company.

Vivanco said the flexible workspace concept offers 3 “work styles” to employees in Mansfield: resident, mobile and home-office. Resident workers, who rarely travel and spend most of their time at their desks, will keep their assigned workspaces at the office. Mobile workers, who often travel  or work remotely, or who are rarely at their desks due to meetings, “will have a variety of shared areas to work within their department neighborhood when they’re on campus, but they won’t have an assigned space,” he said. Home-office workers, who work from home at least 3 days a week, will be offered “shared touch-down spaces” at the Mansfield campus, Vivanco told us.

Covidien once employed as many as 1,700 workers at the site. Today most work in Medtronic’s minimally invasive therapies group, according to the Attleboro Sun Chronicle, although some have administrative duties including information technology, finance, human resources and legal affairs.

Medtronic closed the deal for Covidien Jan. 26, 2015, nearly a year-and-a-half after announcing its plans. The merger, the largest ever for the medical device industry, was structured as a tax inversion that shifted Medtronic’s corporate registration from the U.S. to Ireland, freeing billions in overseas cash.

*Correction, March 9, 2016: Medtronic is not shuttering its operation in Mansfield, as we originally reported. We regret the error. Return to the corrected sentence.

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Covidien, Medtronic, Medtronic buys Covidien

More recent news

  • Ambu wins FDA clearance for first single-use cysto-nephroscope
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy